<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Regeneron Pharmaceuticals - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"XphxmQpAIHwAAn0Oa8gAAAAV","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Regeneron_Pharmaceuticals","wgTitle":"Regeneron Pharmaceuticals","wgCurRevisionId":950877608,"wgRevisionId":950877608,"wgArticleId":5617513,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Regeneron_Pharmaceuticals","wgRelevantArticleId":5617513,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":!0,
"wgMediaViewerEnabledByDefault":!0,"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q7308054","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":!1,"simplifiedTalk":!0},
"wgMinervaDownloadNamespaces":[0]};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.27"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/4/48/New_Eastview_office_bldg_jeh.jpg/1200px-New_Eastview_office_bldg_jeh.jpg"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Regeneron_Pharmaceuticals rootpage-Regeneron_Pharmaceuticals stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Regeneron+Pharmaceuticals" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Regeneron+Pharmaceuticals" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Regeneron Pharmaceuticals</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Regeneron_Pharmaceuticals" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Regeneron+Pharmaceuticals" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0"><p><b>Regeneron Pharmaceuticals, Inc.</b> is an American <a href="/wiki/Biotechnology" title="Biotechnology">biotechnology</a> <a href="/wiki/Company_(law)" class="mw-redirect" title="Company (law)">company</a> headquartered in <a href="/wiki/Eastview,_New_York" title="Eastview, New York">Eastview</a>, near <a href="/wiki/Tarrytown,_New_York" title="Tarrytown, New York">Tarrytown</a>, <a href="/wiki/New_York_(state)" title="New York (state)">New York</a>. The company was founded in 1988.<sup id="cite_ref-herper2013_4-0" class="reference"><a href="#cite_note-herper2013-4">[4]</a></sup>  Originally focused on <a href="/wiki/Neurotrophic_factors" title="Neurotrophic factors">neurotrophic factors</a> and their regenerative capabilities (thus the name), it branched out into the study of both <a href="/wiki/Cytokine" title="Cytokine">cytokine</a> and <a href="/wiki/Tyrosine_kinase" title="Tyrosine kinase">tyrosine kinase</a> receptors.
</p><table class="infobox vcard" style="width:22em"><caption class="fn org">Regeneron Pharmaceuticals, Inc.</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Regeneron_logo.svg" class="image"><img alt="Regeneron logo.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Regeneron_logo.svg/250px-Regeneron_logo.svg.png" decoding="async" width="250" height="30" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Regeneron_logo.svg/375px-Regeneron_logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/48/Regeneron_logo.svg/500px-Regeneron_logo.svg.png 2x" data-file-width="223" data-file-height="27"></a></td></tr><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:New_Eastview_office_bldg_jeh.jpg" class="image"><img alt="New Eastview office bldg jeh.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/48/New_Eastview_office_bldg_jeh.jpg/220px-New_Eastview_office_bldg_jeh.jpg" decoding="async" width="220" height="165" data-file-width="4896" data-file-height="3672"></a><div>Headquarters under construction, 2014</div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><div class="plainlist"><ul><li><a href="/wiki/NASDAQ" class="mw-redirect" title="NASDAQ">NASDAQ</a>: <a rel="nofollow" class="external text" href="https://www.nasdaq.com/symbol/regn">REGN</a></li><li><a href="/wiki/NASDAQ-100" title="NASDAQ-100">NASDAQ-100</a> component</li><li><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500</a> component</li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US75886F1075">US75886F1075 </a><a href="https://www.wikidata.org/wiki/Q7308054?uselang=en#P946" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Pharmaceutical_company" class="mw-redirect" title="Pharmaceutical company">Pharmaceuticals</a>;  <a href="/wiki/Biotech_company" class="mw-redirect" title="Biotech company">Biotech</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1988<span class="noprint">; 32 years ago</span><span style="display:none"> (<span class="bday dtstart published updated">1988</span>)</span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;"><a href="/wiki/Eastview,_New_York" title="Eastview, New York">Eastview</a>, New York, <a href="/wiki/United_States" title="United States">US</a> (Headquarters)</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Area served</div></th><td style="line-height: 1.35em;">Global</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;"><div class="plainlist"><ul><li><a href="/wiki/Leonard_Schleifer" title="Leonard Schleifer">Leonard Schleifer</a> (<a href="/wiki/Chief_Executive_Officer" class="mw-redirect" title="Chief Executive Officer">CEO</a>)</li><li><a href="/wiki/George_Yancopoulos" title="George Yancopoulos">George Yancopoulos</a>, CSO</li></ul></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> $7.86 billion (2019)<sup id="cite_ref-1" class="reference"><a href="#cite_note-1">[1]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> $1.4 billion<sup id="cite_ref-shareholder.com_2-0" class="reference"><a href="#cite_note-shareholder.com-2">[2]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> $5.6 billion<sup id="cite_ref-shareholder.com_2-1" class="reference"><a href="#cite_note-shareholder.com-2">[2]</a></sup></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;">8,100 <sup id="cite_ref-3" class="reference"><a href="#cite_note-3">[3]</a></sup> (2019)</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="http://www.regeneron.com">www<wbr></wbr>.regeneron<wbr></wbr>.com</a></span></td></tr></tbody></table>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#Company_history"><span class="tocnumber">1</span> <span class="toctext">Company history</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Marketed_products"><span class="tocnumber">2</span> <span class="toctext">Marketed products</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Technology_platforms"><span class="tocnumber">3</span> <span class="toctext">Technology platforms</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Financial_performance"><span class="tocnumber">4</span> <span class="toctext">Financial performance</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Key_people"><span class="tocnumber">5</span> <span class="toctext">Key people</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Company_history">Company history</span><span class="mw-editsection"><a href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=1" title="Edit section: Company history" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<p>Regeneron has developed <a href="/wiki/Aflibercept" title="Aflibercept">aflibercept</a>, a <a href="/wiki/VEGF" class="mw-redirect" title="VEGF">VEGF</a> inhibitor, and <a href="/wiki/Rilonacept" title="Rilonacept">rilonacept</a>, an <a href="/wiki/Interleukin-1" class="mw-redirect" title="Interleukin-1">interleukin-1</a> blocker. VEGF is a protein that normally stimulates the growth of blood vessels, and interleukin-1 is a protein that is normally involved in inflammation.
</p><p>On March 26, 2012, Bloomberg announced that <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a> and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72% more than the leading brands. The new drug targets the <a href="/wiki/PCSK9" title="PCSK9">PCSK9</a> gene.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">[5]</a></sup><sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2016)">citation needed</span></a></i>]</sup></p><p>In July 2015, the company announced a new global collaboration with <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a> to discover, develop, and commercialise new immuno-oncology drugs, which could generate more than $2 billion for Regeneron,<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">[6]</a></sup> with $640 million upfront, $750 million for proof of concept data and $650 million from the development of <a href="/wiki/REGN2810" class="mw-redirect" title="REGN2810">REGN2810</a>.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">[7]</a></sup> REGN2810 was later named cemiplimab. In 2019, Regeneron Pharmaceuticals was announced the 7th best <a href="/wiki/Stock" title="Stock">stock</a> of the 2010s, with a total return of 1,457%.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">[8]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Marketed_products">Marketed products</span><span class="mw-editsection"><a href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=2" title="Edit section: Marketed products" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<p>ARCALYST (<a href="/wiki/Rilonacept" title="Rilonacept">rilonacept</a>) for specific, rare <a href="/wiki/Autoinflammatory" class="mw-redirect" title="Autoinflammatory">autoinflammatory</a> conditions. Approved by the FDA in February 2008.
</p><p>EYLEA (<a href="/wiki/Aflibercept" title="Aflibercept">aflibercept</a> injection) Approved by the U.S. Food and Drug Administration (FDA) in November 2011.<sup id="cite_ref-herper2013_4-1" class="reference"><a href="#cite_note-herper2013-4">[4]</a></sup><sup id="cite_ref-apnyt2011_9-0" class="reference"><a href="#cite_note-apnyt2011-9">[9]</a></sup> EYLEA developed to treat a common cause of blindness in the elderly.  EYLEA is reported to cost $11,000 per year for each eye treated.<sup id="cite_ref-forbes-2018_10-0" class="reference"><a href="#cite_note-forbes-2018-10">[10]</a></sup></p><p>ZALTRAP (<a href="/wiki/Aflibercept" title="Aflibercept">aflibercept</a> injection) for metastatic <a href="/wiki/Colorectal_cancer" title="Colorectal cancer">colorectal cancer</a>: Approved by the FDA in August 2012.<sup id="cite_ref-usfdapr2012_11-0" class="reference"><a href="#cite_note-usfdapr2012-11">[11]</a></sup></p><p>PRALUENT (<a href="/wiki/Alirocumab" title="Alirocumab">alirocumab</a>) indicated as an adjunct to diet and maximally tolerated <a href="/wiki/Statin" title="Statin">statin</a> therapy for the treatment of adults with heterozygous <a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">familial hypercholesterolemia</a> or clinical <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerotic cardiovascular disease</a> (ASCVD) who require additional lowering of <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">low-density lipoprotein</a> (LDL) cholesterol. Approved by FDA on 24 July 2015 <sup id="cite_ref-12" class="reference"><a href="#cite_note-12">[12]</a></sup> It is reported to cost $4,500 to $8,000 per year.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">[13]</a></sup></p><p>DUPIXENT (<a href="/wiki/Dupilumab" title="Dupilumab">dupilumab</a> injection) is for the treatment of adolescent and adult patients' <a href="/wiki/Atopic_dermatitis" title="Atopic dermatitis">atopic dermatitis</a>. Approved by FDA on 28 March 2017.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">[14]</a></sup>  It is reported to cost $37,000 per year.<sup id="cite_ref-forbes-2018_10-1" class="reference"><a href="#cite_note-forbes-2018-10">[10]</a></sup></p><p>KEVZARA (<a href="/wiki/Sarilumab" title="Sarilumab">sarilumab</a> injection) is an interleukin-6 (IL-6) receptor antagonist for treatment of adult patients with <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>. Approved by FDA on 22 May 2017.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">[15]</a></sup>  Trials commenced on March 16 2020 to evaluate the effectiveness of Kevzara in the treatment of COVID-19.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">[16]</a></sup><sup id="cite_ref-17" class="reference"><a href="#cite_note-17">[17]</a></sup></p><p>LIBTAYO (<a href="/wiki/Cemiplimab" title="Cemiplimab">cemiplimab</a> injection) is a monoclonal antibody targeting the PD-1 pathway as a checkpoint inhibitor, for the treatment of patients with metastatic cutaneous <a href="/wiki/Squamous_cell_carcinoma" title="Squamous cell carcinoma">squamous cell carcinoma</a> (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. Approved by FDA on 28 September 2018.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">[18]</a></sup></p><p><a href="/wiki/REGN-EB3" title="REGN-EB3">REGN-EB3</a> is a drug made of three <a href="/wiki/Antibodies" class="mw-redirect" title="Antibodies">antibodies</a>, developed to treat <a href="/wiki/Ebola" class="mw-redirect" title="Ebola">Ebola</a>. Among patients treated with it, 71% recovered; the mortality rate improved if the drug was administered soon after infection, at a 94% survival rate, in a timely diagnosis- critical for those infected with dangerous diseases like Ebola that can cause <a href="/wiki/Sepsis" title="Sepsis">sepsis</a> and, eventually, <a href="/wiki/Multiple_organ_dysfunction_syndrome" title="Multiple organ dysfunction syndrome">multiple organ dysfunction syndrome</a>, more quickly than other diseases. This makes Ebola potentially a treatable disease.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">[19]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Technology_platforms">Technology platforms</span><span class="mw-editsection"><a href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=3" title="Edit section: Technology platforms" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<p>Trap Fusion Proteins: Regeneron's novel and patented Trap technology creates high-affinity product candidates for many types of signaling molecules, including growth factors and cytokines. The Trap technology involves fusing two distinct fully human receptor components and a fully human immunoglobulin-G constant region.
</p><p>Fully Human Monoclonal Antibodies: Regeneron has developed a suite (VelociSuite) of patented technologies, including VelocImmune and VelociMab, that allow Regeneron scientists to determine the best targets for therapeutic intervention and rapidly generate high-quality, fully human antibodies drug candidates addressing these targets.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20">[20]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>255–258</span></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Financial_performance">Financial performance</span><span class="mw-editsection"><a href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=4" title="Edit section: Financial performance" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<table class="wikitable"><tbody><tr><th>Financial Year</th>
<th>Revenue</th>
<th>Ref
</th></tr><tr><td>2012</td>
<td>$1.4 billion</td>
<td><sup id="cite_ref-xbrlus_1_21-0" class="reference"><a href="#cite_note-xbrlus_1-21">[21]</a></sup></td></tr><tr><td>2013</td>
<td>$2.1 billion</td>
<td><sup id="cite_ref-xbrlus_1_21-1" class="reference"><a href="#cite_note-xbrlus_1-21">[21]</a></sup></td></tr><tr><td>2014</td>
<td>$2.8 billion</td>
<td><sup id="cite_ref-shareholder.com_2-2" class="reference"><a href="#cite_note-shareholder.com-2">[2]</a></sup></td></tr><tr><td>2015</td>
<td>$4.1 billion</td>
<td><sup id="cite_ref-shareholder.com_2-3" class="reference"><a href="#cite_note-shareholder.com-2">[2]</a></sup></td></tr><tr><td>2016</td>
<td>$4.8 billion</td>
<td><sup id="cite_ref-shareholder.com_2-4" class="reference"><a href="#cite_note-shareholder.com-2">[2]</a></sup></td></tr><tr><td>2017
</td>
<td>$5.8 billion
</td>
<td><sup id="cite_ref-shareholder.com_2-5" class="reference"><a href="#cite_note-shareholder.com-2">[2]</a></sup></td></tr><tr><td>2018
</td>
<td>$6.7 billion
</td>
<td><sup id="cite_ref-shareholder.com_2-6" class="reference"><a href="#cite_note-shareholder.com-2">[2]</a></sup></td></tr></tbody></table></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Key_people">Key people</span><span class="mw-editsection"><a href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=5" title="Edit section: Key people" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<p>The company was founded by CEO <a href="/wiki/Leonard_Schleifer" title="Leonard Schleifer">Leonard Schleifer</a> and scientist <a href="/wiki/George_Yancopoulos" title="George Yancopoulos">George Yancopoulos</a>.  They are reported to hold $1.3 billion and $900 million in company stock, respectively.  Both are from <a href="/wiki/Queens,_New_York" class="mw-redirect" title="Queens, New York">Queens, New York</a>.<sup id="cite_ref-forbes-2018_10-2" class="reference"><a href="#cite_note-forbes-2018-10">[10]</a></sup></p><p>Schleifer was formerly a professor of medicine at Weill Cornell Medical School.  Yancopoulos was an assistant professor at Columbia University.  Yancopoulos was involved in each drug's development.<sup id="cite_ref-forbes-2018_10-3" class="reference"><a href="#cite_note-forbes-2018-10">[10]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(6)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><a href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=6" title="Edit section: See also" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-6 collapsible-block" id="mf-section-6">
<ul><li><a href="/wiki/Biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area" class="mw-redirect" title="Biotech and pharmaceutical companies in the New York metropolitan area">Biotech and pharmaceutical companies in the New York metropolitan area</a></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(7)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="References">References</span><span class="mw-editsection"><a href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=7" title="Edit section: References" data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-7 collapsible-block" id="mf-section-7">
<div class="reflist" style="list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="references"><li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://investor.regeneron.com/node/23216/html">https://investor.regeneron.com/node/23216/html</a></span>
</li>
<li id="cite_note-shareholder.com-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-shareholder.com_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-shareholder.com_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-shareholder.com_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-shareholder.com_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-shareholder.com_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-shareholder.com_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-shareholder.com_2-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><a rel="nofollow" class="external autonumber" href="http://files.shareholder.com/downloads/REGN/2773703469x0x873937/63301CCD-A156-46CE-8521-64D7984E3107/REGN_News_2016_2_9_General_Releases.pdf">[1]</a><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title=" Dead link since June 2019">dead link</span></a></i>]</span></sup></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://investor.regeneron.com/node/23216/html">https://investor.regeneron.com/node/23216/html</a></span>
</li>
<li id="cite_note-herper2013-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-herper2013_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-herper2013_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Herper, Matthew (August 14, 2013). <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/matthewherper/2013/08/14/how-two-guys-from-queens-are-changing-drug-discovery/">"How Two Guys From Queens Are Changing Drug Discovery"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>. United States. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140316003731/http://www.forbes.com/sites/matthewherper/2013/08/14/how-two-guys-from-queens-are-changing-drug-discovery/">Archived</a> from the original on March 16, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">March 22,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=How+Two+Guys+From+Queens+Are+Changing+Drug+Discovery&amp;rft.date=2013-08-14&amp;rft.au=Herper%2C+Matthew&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2013%2F08%2F14%2Fhow-two-guys-from-queens-are-changing-drug-discovery%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style><span style="position:relative; top: -2px;"><a href="/wiki/Open_access" title="open access publication – free to read"><noscript><img alt="open access" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/9px-Open_Access_logo_PLoS_transparent.svg.png" decoding="async" width="9" height="14" data-file-width="640" data-file-height="1000"></noscript><span class="lazy-image-placeholder" style="width: 9px;height: 14px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/9px-Open_Access_logo_PLoS_transparent.svg.png" data-alt="open access" data-width="9" data-height="14" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/14px-Open_Access_logo_PLoS_transparent.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/18px-Open_Access_logo_PLoS_transparent.svg.png 2x"> </span></a></span></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><cite class="citation news">Husten, Larry. <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/larryhusten/2015/01/26/sanofi-and-regeneron-leapfrog-amgen-in-new-cholesterol-drug-race/#11360b5e6ef3">"Sanofi And Regeneron Leapfrog Amgen In New Cholesterol Drug Race"</a>. <i>Forbes</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-02-22</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=Sanofi+And+Regeneron+Leapfrog+Amgen+In+New+Cholesterol+Drug+Race&amp;rft.aulast=Husten&amp;rft.aufirst=Larry&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Flarryhusten%2F2015%2F01%2F26%2Fsanofi-and-regeneron-leapfrog-amgen-in-new-cholesterol-drug-race%2F%2311360b5e6ef3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/regeneron-sanofi-launch-2b-immuno-oncology-collaboration/81251558/">"Regeneron, Sanofi Launch $2B+ Immuno-Oncology Collaboration - GEN News Highlights - GEN"</a>. 2015-07-28.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Regeneron%2C+Sanofi+Launch+%242B%2B+Immuno-Oncology+Collaboration+-+GEN+News+Highlights+-+GEN&amp;rft.date=2015-07-28&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fregeneron-sanofi-launch-2b-immuno-oncology-collaboration%2F81251558%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercebiotech.com/story/struggling-sanofi-paying-18b-partner-regeneron-immuno-oncology/2015-07-28">"UPDATED: Struggling Sanofi paying $1.8B to partner with Regeneron on immuno-oncology - FierceBiotech"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=UPDATED%3A+Struggling+Sanofi+paying+%241.8B+to+partner+with+Regeneron+on+immuno-oncology+-+FierceBiotech&amp;rft_id=http%3A%2F%2Fwww.fiercebiotech.com%2Fstory%2Fstruggling-sanofi-paying-18b-partner-regeneron-immuno-oncology%2F2015-07-28&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><cite class="citation web">Hough, Jack. <a rel="nofollow" class="external text" href="https://www.barrons.com/articles/the-10-best-stocks-of-the-past-decade-51576628081">"10 Stocks That Had Better Decades Than Amazon and Google"</a>. <i>www.barrons.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2019-12-19</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.barrons.com&amp;rft.atitle=10+Stocks+That+Had+Better+Decades+Than+Amazon+and+Google&amp;rft.aulast=Hough&amp;rft.aufirst=Jack&amp;rft_id=https%3A%2F%2Fwww.barrons.com%2Farticles%2Fthe-10-best-stocks-of-the-past-decade-51576628081&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-apnyt2011-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-apnyt2011_9-0">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2011/11/19/business/regulators-approve-a-drug-for-an-eye-condition.html">"Regulators Approve a Drug for an Eye Condition"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. Associated Press. November 18, 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Regulators+Approve+a+Drug+for+an+Eye+Condition&amp;rft.date=2011-11-18&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2011%2F11%2F19%2Fbusiness%2Fregulators-approve-a-drug-for-an-eye-condition.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><span style="font-size:0.95em; font-size:90%; color:#555">(<a href="/wiki/Wikipedia:Verifiability#Access_to_sources" title="Wikipedia:Verifiability">registration required</a>)</span></span>
</li>
<li id="cite_note-forbes-2018-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-forbes-2018_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-forbes-2018_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-forbes-2018_10-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-forbes-2018_10-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.forbes.com/sites/forbesdigitalcovers/2018/07/26/regenerons-billionaire-founder-battles-the-drug-pricing-system/">"Regeneron's Billionaire Founder Battles The Drug Pricing System"</a>. <i>Forbes</i>. 26 July 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">26 July</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Regeneron%27s+Billionaire+Founder+Battles+The+Drug+Pricing+System&amp;rft.date=2018-07-26&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fforbesdigitalcovers%2F2018%2F07%2F26%2Fregenerons-billionaire-founder-battles-the-drug-pricing-system%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-usfdapr2012-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-usfdapr2012_11-0">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm314372.htm">"FDA approves Zaltrap for metastatic colorectal cancer"</a> (Press release). U.S. Food and Drug Administration. August 3, 2012. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130625115621/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm314372.htm">Archived</a> from the original on June 25, 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+Zaltrap+for+metastatic+colorectal+cancer&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft.date=2012-08-03&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm314372.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20150727112659/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455883.htm">"Archived copy"</a>. Archived from <a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455883.htm">the original</a> on 2015-07-27<span class="reference-accessdate">. Retrieved <span class="nowrap">2015-07-29</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm455883.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (<a href="/wiki/Category:CS1_maint:_archived_copy_as_title" title="Category:CS1 maint: archived copy as title">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><cite class="citation news">Tirrell, Meg (2018-05-01). <a rel="nofollow" class="external text" href="https://www.cnbc.com/2018/05/01/regeneron-sanofi-chop-cholesterol-drug-price-in-express-scripts-pact.html">"A $14,000 cholesterol drug gets a price cut as Regeneron, Sanofi strike deal with Express Scripts"</a>. <i>CNBC</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2018-08-22</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNBC&amp;rft.atitle=A+%2414%2C000+cholesterol+drug+gets+a+price+cut+as+Regeneron%2C+Sanofi+strike+deal+with+Express+Scripts&amp;rft.date=2018-05-01&amp;rft.aulast=Tirrell&amp;rft.aufirst=Meg&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2018%2F05%2F01%2Fregeneron-sanofi-chop-cholesterol-drug-price-in-express-scripts-pact.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><cite class="citation web">Inc., Regeneron Pharmaceuticals. <a rel="nofollow" class="external text" href="http://www.prnewswire.com/news-releases/regeneron-and-sanofi-announce-fda-approval-of-dupixent-dupilumab-the-first-targeted-biologic-therapy-for-adults-with-moderate-to-severe-atopic-dermatitis-300430441.html">"Regeneron and Sanofi Announce FDA Approval of DUPIXENT® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis"</a>. <i>www.prnewswire.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.prnewswire.com&amp;rft.atitle=Regeneron+and+Sanofi+Announce+FDA+Approval+of+DUPIXENT%C2%AE+%28dupilumab%29%2C+the+First+Targeted+Biologic+Therapy+for+Adults+with+Moderate-to-Severe+Atopic+Dermatitis&amp;rft.aulast=Inc.&amp;rft.aufirst=Regeneron+Pharmaceuticals&amp;rft_id=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fregeneron-and-sanofi-announce-fda-approval-of-dupixent-dupilumab-the-first-targeted-biologic-therapy-for-adults-with-moderate-to-severe-atopic-dermatitis-300430441.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://newsroom.regeneron.com/releasedetail.cfm?ReleaseID=1027419">"Regeneron and Sanofi Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients (NASDAQ:REGN)"</a>. <i>newsroom.regeneron.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=newsroom.regeneron.com&amp;rft.atitle=Regeneron+and+Sanofi+Announce+FDA+Approval+of+Kevzara%C2%AE+%28sarilumab%29+for+the+Treatment+of+Moderately+to+Severely+Active+Rheumatoid+Arthritis+in+Adult+Patients+%28NASDAQ%3AREGN%29&amp;rft_id=http%3A%2F%2Fnewsroom.regeneron.com%2Freleasedetail.cfm%3FReleaseID%3D1027419&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.regeneron.com/covid19">"Regeneron's COVID-19 Response Efforts"</a>. <i>www.regeneron.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.regeneron.com&amp;rft.atitle=Regeneron%27s+COVID-19+Response+Efforts&amp;rft_id=https%3A%2F%2Fwww.regeneron.com%2Fcovid19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://clinicaltrials.gov/ct2/show/NCT04315298">"Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19"</a>. <i>clinicaltrials.gov</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=Evaluation+of+the+Efficacy+and+Safety+of+Sarilumab+in+Hospitalized+Patients+With+COVID-19&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT04315298&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622044.htm">"FDA approves first treatment for advanced form of the second most common skin cancer (NASDAQ:REGN)"</a>. <i>fda.gov/NewsEvents</i>. 2019-09-11.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=fda.gov%2FNewsEvents&amp;rft.atitle=FDA+approves+first+treatment+for+advanced+form+of+the+second+most+common+skin+cancer+%28NASDAQ%3AREGN%29&amp;rft.date=2019-09-11&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm622044.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.msn.com/en-us/news/world/ebola-is-now-a-disease-we-can-treat-how-a-cure-emerged-from-a-war-zone/ar-AAJA1MI?ocid=spartanntp">"<span class="cs1-kern-left">'</span>Ebola is Now a Disease We Can Treat.' How a Cure Emerged from a War Zone"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=%27Ebola+is+Now+a+Disease+We+Can+Treat.%27+How+a+Cure+Emerged+from+a+War+Zone&amp;rft_id=https%3A%2F%2Fwww.msn.com%2Fen-us%2Fnews%2Fworld%2Febola-is-now-a-disease-we-can-treat-how-a-cure-emerged-from-a-war-zone%2Far-AAJA1MI%3Focid%3Dspartanntp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text">Susana Magadán Mompó and África González-Fernández.  Human Monoclonal Antibodies from Transgenic Mice. Chapter 13 in <a rel="nofollow" class="external text" href="http://www.nascentbiotech.com/wp-content/uploads/2014/09/Human_Monoclonal_Antibodies_2013_Whole_Book.pdf">Human Monoclonal Antibodies: Methods and Protocols</a>  Ed. Michael Steinitz. Springer Science+Business Media, 2014. <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1-62703-585-9" title="Special:BookSources/978-1-62703-585-9">978-1-62703-585-9</a></span>
</li>
<li id="cite_note-xbrlus_1-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-xbrlus_1_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-xbrlus_1_21-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/872589/000153217614000008/0001532176-14-000008-index.htm">"REGENERON PHARMACEUTICALS INC 2013 Annual Report Form (10-K)"</a> <span class="cs1-format">(XBRL)</span>. United States Securities and Exchange Commission. February 13, 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=REGENERON+PHARMACEUTICALS+INC+2013+Annual+Report+Form+%2810-K%29&amp;rft.pub=United+States+Securities+and+Exchange+Commission&amp;rft.date=2014-02-13&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F872589%2F000153217614000008%2F0001532176-14-000008-index.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ARegeneron+Pharmaceuticals" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(8)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Regeneron_Pharmaceuticals&amp;action=edit&amp;section=8" title="Edit section: External links" data-section="8" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-8 collapsible-block" id="mf-section-8">
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000"><tbody><tr>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Regeneron" class="extiw" title="commons:Category:Regeneron"><span style="">Regeneron</span></a></b></i>.</td></tr></tbody></table><ul><li><span class="official-website"><span class="url"><a rel="nofollow" class="external text" href="http://www.regeneron.com">Official website</a></span></span></li>
<li>Business data for Regeneron: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=REGN">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=REGN">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=REGN">SEC filings</a></li></ul></div></li>
<li><a rel="nofollow" class="external text" href="https://www.nytimes.com/2011/11/21/business/eylea-a-vision-drug-wins-long-sought-approval.html">Success Long in Coming for Eylea, a Vision Treatment</a></li></ul>





</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Regeneron_Pharmaceuticals&amp;oldid=950877608">https://en.wikipedia.org/w/index.php?title=Regeneron_Pharmaceuticals&amp;oldid=950877608</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Regeneron_Pharmaceuticals"
				data-user-name="Pasuarezb"
				data-user-gender="unknown"
				data-timestamp="1586856565">
				<span>Last edited on 14 April 2020, at 09:29</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Regeneron_Pharmaceuticals&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.512","walltime":"0.707","ppvisitednodes":{"value":2595,"limit":1000000},"postexpandincludesize":{"value":88099,"limit":2097152},"templateargumentsize":{"value":4556,"limit":2097152},"expansiondepth":{"value":17,"limit":40},"expensivefunctioncount":{"value":2,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":60829,"limit":5000000},"entityaccesscount":{"value":1,"limit":400},"timingprofile":["100.00%  604.006      1 -total"," 34.99%  211.333      1 Template:Reflist"," 34.08%  205.828      1 Template:Infobox_company"," 31.58%  190.738      1 Template:Infobox"," 11.90%   71.886      4 Template:Cite_news"," 11.32%   68.384      1 Template:Citation_needed"," 11.01%   66.500      9 Template:Wikidata"," 10.64%   64.296      2 Template:Fix"," 10.48%   63.301      1 Template:Br_separated_entries","  8.05%   48.610     12 Template:Cite_web"]},"scribunto":{"limitreport-timeusage":{"value":"0.229","limit":"10.000"},"limitreport-memusage":{"value":7198562,"limit":52428800}},"cachereport":{"origin":"mw1372","timestamp":"20200416051342","ttl":86400,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Regeneron Pharmaceuticals","url":"https:\/\/en.wikipedia.org\/wiki\/Regeneron_Pharmaceuticals","sameAs":"http:\/\/www.wikidata.org\/entity\/Q7308054","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q7308054","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2006-06-18T23:09:42Z","dateModified":"2020-04-14T09:29:25Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/4\/48\/New_Eastview_office_bldg_jeh.jpg","headline":"pharmaceutical company"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":111,"wgHostname":"mw1407"});});</script>		</body>
		</html>
		